Digestive & Intestinal Remedies (Pharmacies) - Central America

  • Central America
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$115.40m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.80%, resulting in a market volume of US$145.90m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.18 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Central America has witnessed significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Central America have played a crucial role in shaping the Digestive & Intestinal Remedies market. With an increasing awareness of health and wellness, consumers are becoming more proactive in managing their digestive health. They are seeking products that provide quick relief from common digestive issues such as indigestion, heartburn, and bloating. Additionally, there is a growing preference for natural and herbal remedies, as consumers are becoming more conscious about the potential side effects of synthetic medications. Several trends have emerged in the Digestive & Intestinal Remedies market in Central America. One of the key trends is the rising demand for over-the-counter (OTC) products. Consumers are increasingly self-diagnosing and self-medicating for minor digestive issues, leading to a surge in sales of OTC remedies. This trend is driven by convenience and cost-effectiveness, as OTC products are readily available in pharmacies without the need for a prescription. Another trend in the market is the growing popularity of probiotics and other gut health supplements. Probiotics are live bacteria that promote a healthy gut microbiome and aid digestion. They have gained traction among consumers who are seeking natural solutions for maintaining digestive health. The market has seen an influx of probiotic supplements, including capsules, powders, and even functional foods and beverages. Local special circumstances in Central America have also contributed to the development of the Digestive & Intestinal Remedies market. The region has a high prevalence of gastrointestinal diseases and disorders, which has created a significant demand for remedies. Factors such as poor sanitation, inadequate access to clean water, and a lack of awareness about proper hygiene practices contribute to the high incidence of digestive issues. This has created a fertile market for companies offering remedies to address these concerns. Underlying macroeconomic factors have also played a role in the growth of the Digestive & Intestinal Remedies market in Central America. Economic development and rising disposable incomes have increased healthcare spending, including on digestive health products. As the middle class expands and more people have access to healthcare, the demand for remedies is expected to continue growing. In conclusion, the Digestive & Intestinal Remedies market in Central America is developing due to customer preferences for quick relief, natural remedies, and self-medication. The market is also influenced by trends such as the demand for OTC products and the popularity of probiotics. Local special circumstances, including a high prevalence of digestive issues, further drive the market. The underlying macroeconomic factors of economic development and rising disposable incomes also contribute to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)